MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
3.271
-0.009 (-0.28%)
Nov 21, 2024, 12:12 PM EST - Market open
MacroGenics Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for MacroGenics stock have an average target of 8.57, with a low estimate of 4.00 and a high estimate of 17. The average target predicts an increase of 162.02% from the current stock price of 3.27.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for MacroGenics stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 3 | 3 | 3 | 2 |
| Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Hold | 4 | 6 | 7 | 7 | 7 | 8 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 12 | 12 | 12 | 12 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $4 | Hold | Reiterates | $4 | +22.30% | Nov 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $4 | Hold | Reiterates | $4 | +22.30% | Sep 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $4 | Hold | Reiterates | $4 | +22.30% | Aug 21, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $16 → $14 | Strong Buy | Maintains | $16 → $14 | +328.04% | Aug 15, 2024 |
Financial Forecast
Revenue This Year
129.03M
from 58.75M
Increased by 119.63%
Revenue Next Year
89.88M
from 129.03M
Decreased by -30.34%
EPS This Year
-1.41
from -0.15
EPS Next Year
-2.31
from -1.41
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 195.3M | 161.2M | 240.2M | ||
| Avg | 129.0M | 89.9M | 94.7M | ||
| Low | 43.7M | 20.8M | 21.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 232.4% | 25.0% | 167.2% | ||
| Avg | 119.6% | -30.3% | 5.3% | ||
| Low | -25.6% | -83.9% | -75.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.38 | -1.34 | -0.61 | ||
| Avg | -1.41 | -2.31 | -2.15 | ||
| Low | -1.78 | -3.19 | -4.61 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.